TY - JOUR
KW - 3233:Substance Abuse & Addiction
KW - 3340:Clinical Psychopharmacology
KW - Adulthood (18 yrs & older)
KW - article
KW - buprenorphine
KW - Drug Addiction
KW - Drug Therapy
KW - Empirical Study
KW - Female
KW - Human
KW - Male
KW - Middle Age (40-64 yrs)
KW - naloxone
KW - patient perspectives
KW - qualitative
KW - Qualitative Study
KW - Retention
KW - Thirties (30-39 yrs)
KW - Treatment Outcomes
KW - US
KW - Young Adulthood (18-29 yrs)
AU - Cheryl Teruya
AU - Robert P. Schwartz
AU - Shannon Gwin Mitchell
AU - Albert L. Hasson
AU - Christie Thomas
AU - Samantha H. Buoncristiani
AU - Yih-Ing Hser
AU - Katharina Wiest
AU - Allan J. Cohen
AU - Naomi Glick
AU - Petra Jacobs
AU - Paul McLaughlin
AU - Walter Ling
A1 - 
BT - Journal of psychoactive drugs
C5 - Opioids & Substance Use
CP - 5
IS - 5
JF - Journal of psychoactive drugs
PB - Taylor & Francis Haight-Ashbury Publications
PY - 2014
SN - 0279-1072, 0279-1072
SP - 412
EP - 426
EP - 
T1 - Patient perspectives on buprenorphine/naloxone: A qualitative study of retention during the Starting Treatment with Agonist Replacement Therapies (START) Study.
T2 - Journal of psychoactive drugs
TI - Patient perspectives on buprenorphine/naloxone: A qualitative study of retention during the Starting Treatment with Agonist Replacement Therapies (START) Study.
U1 - Opioids & Substance Use
UR - http://search.proquest.com/docview/1636820948?accountid=28100
VL - 46
VO - 0279-1072, 0279-1072
Y1 - 2014
ER -